NCT05933018 is a NA clinical trial of liver elastography in Type1diabetes, sponsored by HaEmek Medical Center, Israel.

Who is sponsoring NCT05933018?

NCT05933018 is sponsored by HaEmek Medical Center, Israel.

What drugs are being tested in NCT05933018?

Interventions in NCT05933018: liver elastography.

What condition does NCT05933018 study?

NCT05933018 studies Type1diabetes, Fatty Liver.

Is NCT05933018 still recruiting?

NCT05933018 is currently status unknown. Last updated 6 July 2023.

Last reviewed 2023-07-06 · How we verify

NCT05933018

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Night Hyperglycemia and Fatty Liver in Type 1 Diabetes

Status unknown NA Last updated 6 July 2023

What this trial tests

NA trial testing liver elastography in Type1diabetes in 120 participants. Status unknown.

Timeline

15 January 2023

Primary endpoint
15 July 2024

15 July 2024

Quick facts

Lead sponsor	HaEmek Medical Center, Israel
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	diagnostic
Enrollment	120
Start date	15 January 2023
Primary completion	15 July 2024
Estimated completion	15 July 2024
Sites	1 location across Israel

Drugs / interventions tested

liver elastography

Conditions studied

Type1diabetes — all drugs for Type1diabetes →
Fatty Liver — all drugs for Fatty Liver →

Sponsor

HaEmek Medical Center, Israel

Who can join

Adults 18 to 65, any sex, with Type1diabetes or Fatty Liver. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This clinical trial aims to discover the relationship between hyperglycemia at night and early morning hours and the presence of fatty liver in patients with type 1 diabetes. The main question it aims to answer are: • if hyperglycemic patterns related to metabolic parameters in type 1 diabetes The data from the insulin pump and sensor will be processed. The patients will be divided into two groups. One group without night hyperglycemia and the other with night hyperglycemia. Investigators will perform liver elastography for these two groups. The presence or absence of hepatic steatosis will be evaluated in these groups according to the data.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Type1diabetes

Currently open trials in the same condition.

NCT07139808 — Safety and Effectiveness of A Novel Continuous Glucose and Ketone Monitoring System · NA · recruiting
NCT07092761 — Evaluation of the Accuracy and Safety of A Novel Real-Time Continuous Glucose Monitoring System · NA · recruiting
NCT06646107 — Adherence to Mediterranean Diet in Type 1 Diabetes Initiating Minimed 780G: Glucose Metrics vs Insulin Metrics, is There · recruiting
NCT06753994 — Continuous Ketone Monitoring in People With Type 1 Diabetes Using SGLT2 Inhibitors · Phase 1 · recruiting
NCT05668507 — REACHOUT Mental Health Support Mobile App · NA · active not recruiting

Other HaEmek Medical Center, Israel trials

Trials by the same sponsor.

NCT06656286 — Hysteroscopic Intrauterine Suturing · NA · not yet recruiting
NCT06803992 — Induction of Labor - Comparison Propess With Prostaglandin E2 Vaginal Gel and Balloon Catheter · Phase 4 · recruiting
NCT06542367 — Trans Canal Tympanoplasty With Local Anesthesia Using Fat Graft and "TachoSil" · NA · not yet recruiting
NCT05732155 — Preliminary Effectiveness of Individual and Group MDMA-assisted Therapy for Israeli Veterans With PTSD and Moral Injury. · Phase 2 · unknown
NCT02637986 — The Efficacy of Orally Administrated Probiotic Formula in Preventing a Recurrence of a Urinary Tract Infection During Pr · NA · withdrawn

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05933018 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by HaEmek Medical Center, Israel
Last refreshed: 6 July 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05933018.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing